Patents
Industry Leading Patented Technology
BioStem Technologies, Inc. is at the forefront of advanced wound care, leveraging cutting-edge innovations derived from amniotic tissue. Our robust patent portfolio reflects our deep commitment to research and development, underscoring our drive to expand innovations in wound care through pioneering discoveries and next-generation products.
Many of these patents form the foundation of our proprietary amniotic tissue-based technologies, which are currently available in the market. Additionally, certain patents relate to technologies that may support future product development opportunities within our long-term pipeline, ensuring that we continue to lead the way in innovative wound care solutions.
Patent Notice
This page is intended to serve as notice under 35 U.S.C. § 287(a). This list may not be exhaustive. BioStem’s products may be protected by one or more patents, and not all patents listed below may cover every one of BioStem’s products. BioStem reserves the right to correct any errors, inaccuracies, or omissions on this page and to update this page at any time without prior notice.
The following patents and published patent applications are owned by or licensed to BioStem Technologies, Inc. and relate to one or more of BioStem's Amniotic Tissue Technologies.
U.S. and International Patents and Patent Application Publications
- US – 11,844,876
- US – 12,285,445
- DE – 4442316
- US – 12,370,223
- NL – 2033318
- EP – 4358981
- ES – 4442316
- DE – 4358981
- US – D1085424
- US – 12,263,191
- FR – 4442316
- ES – 4358981
- US – D1085425
- US – 12,144,831
- GB – 4442316
- FR – 4358981
- NL – 2034251
- EP – 4442316
- IT – 4442316
- IT – 4358981
- GB – 4358981
- US – 12,478,647
- US – 12,648,969
- US – D1131805
- US – D1130758
- US – D1130759
- US – D1130760
- EU – 015128595-0001
- EU – 015128595-0002
- EU – 015128595-0003
- EU – 015128595-0004
- EU – 015128595-0005
- GB – 6494869
- GB – 6494870
- GB – 6494871
- GB – 6494872
- GB – 6494873
- US – 9,526,770
- US – 9,675,733
- US – 9,012,222
- AU – 2024284510A1
- US – 20220031761A1
- US – 20220370508A1
- US – 20240226181A1
- US – 20240082460A1
- WO – 2024151724A1
- EP – 4395798A4
- EP – 4395797A4
- WO – 2024254231A3
- US – 20240408148A1
- US – 20250262249A1
- AU – 2023315778A1
- CA – 3263067A1
- EP – 4561595A2
- JP – 2025524108A
- MX – 2025000959A
- AU – 2023255390A1
- BR – 112024021719
- CA – 3255906A1
- EP – 4511046A4
- JP – 2025513923A
- MX – 2024013009A
- AU – 2023299174A1
- BR – 112024027415
- CA – 3260775A1
- JP – 2025522892A
- MX – 2025000161A
- AU – 2023297925A1
- BR – 112024027417
- CA – 3260661A1
- JP – 2025522893A5
- MX – 2025000164A
- AU – 2023297923A1
- BR – 112024027409
- CA – 3260662A1
- JP – 2025524577A
- MX – 2025000165A
- US – 20250186506A1
- US – 20250295702A1
- CN – 120813363A
- BR – 112025014261
- CA – 3279415A1
- JP – 2026503288A
- MX – 2025008128A
- AU – 2024208464A1
- EP – 4648784A1
- US – 20260069640A1
- CA – 3293052A1
- CN – 121311232A
- MX – 2025013888A
- EP – 4698196A2
- EP – 4741008A2
Last updated: July 23, 2026
The following patents and pending patent applications are owned by or licensed to BioStem Technologies, Inc. and cover one or more of BioStem's Tissue Mincing Tool technologies.
U.S. and International Patents and Patent Application Publications
- US – 9,145,544
- FI – 2775928
- QA – 518/2024
- EU – 002558890-0001
- AU – 2012335746
- FR – 2775928
- SE – 2775928
- EU – 002558890-0002
- BE – 2775928
- GB – 2775928
- SG – 11201402149T
- HK – 1401964.0M
- CA – 2862437
- GR – 2775928
- US – 8,893,995
- IN – 39380
- CH – 2775928
- IE – 2775928
- US – 8,967,513
- IL – 56145
- CN – 201280055019.5
- IL – 232290
- US – 8,967,512
- SG – D2014/1269/C
- CZ – 2775928
- NL – 2775928
- US – 9,663,760
- GB – 002558890-0001
- DE – 2775928
- NO – 2775928
- EP – 2775928
- GB – 002558890-0002
- DK – 2775928
- PL – 2775928
- JP – 6159729
- US – D716601
- ES – 2775928
- PT – 2775928
- HK – 1195866
- US – D717587
Last updated: July 23, 2026